For the monthly distribution period from: February 17, 2024 to March 15, 2024
Commission File Number of issuing entity: 333-262701-01
Central Index Key Number of issuing entity: 0001921064
BENCHMARK 2022-B35 MORTGAGE TRUST(Exact name of issuing entity as... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐
Preliminary Proxy Statement
☐
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐
Definitive Proxy... (continue reading...)
Commission File Number of issuing entity: 333-262701-01
Central Index Key Number of issuing entity: 0001921064
BENCHMARK 2022-B35 MORTGAGE TRUST (Exact name of issuing entity as specified in its charter)
Commission File Number of depositor: 333-262701
Central Index Key Number of depositor: 0001258361
More SEC Filings
View Older Stories-
Form ARS PAPA JOHNS INTERNATIONAL For: Dec 31
-
Form MA-A Argent Advisors, Inc. For: Dec 31
-
Form 424B2 BofA Finance LLC
-
Form ARS BRIGHTCOVE INC For: Dec 31
-
Form 4 ACCO BRANDS Corp For: Mar 27 Filed by: Kroeger Thomas
-
Form 15-12G CURO Group Holdings Corp
-
Form 6-K SatixFy Communications For: Mar 29
-
Form 10-K KALA BIO, Inc. For: Dec 31
-
Form 4 ACCO BRANDS Corp For: Mar 27 Filed by: Keller Robert J
-
Form SC 13D/A Genetron Holdings Ltd Filed by: Wang Sizhen
-
Form 8-K AILERON THERAPEUTICS For: Mar 25
-
Form ARS AXCELIS TECHNOLOGIES For: Dec 31
-
Form ARS CHARLES RIVER LABORATORI For: Dec 30
-
Form D Fairmount Healthcare
-
Form 20-F SatixFy Communications For: Dec 31
-
Form PRE 14A Gannett Co., Inc. For: Jun 03
-
Form NT 10-K VNUE, Inc. For: Dec 31
-
Form 8-K KALA BIO, Inc. For: Mar 29
-
Form DEF 14A AXCELIS TECHNOLOGIES For: May 09
-
Form DEF 14A PAPA JOHNS INTERNATIONAL For: May 02
-
Form NT 10-K Adorbs Inc For: Dec 31
-
Form NT 10-K Winvest Group Ltd For: Dec 31
-
Form DEF 14A CHARLES RIVER LABORATORI For: May 08
-
Form NT 10-K Viveon Health Acquisitio For: Dec 31
-
Form 10-K TANCHENG GROUP CO., LTD. For: Dec 31
-
Form 8-K Ensysce Biosciences, For: Mar 29
-
Form NT 10-K Data Call Technologies For: Dec 31
-
Form 8-K COFFEE HOLDING CO INC For: Mar 28
-
Form RW Opti-Harvest, Inc.
-
Form NT 10-K Greenland Technologies For: Dec 31
-
Form NT 10-K JRSIS HEALTH CARE Corp For: Dec 31
-
Form NT 10-K Vocodia Holdings Corp For: Dec 31
-
Form 8-K Sow Good Inc. For: Mar 28
-
Form 6-K Legend Biotech Corp For: Mar 29
-
Form NT 10-K GBT Technologies Inc. For: Dec 31
-
Form 8-K AFC Gamma, Inc. For: Mar 26
-
Form NT 10-K Emeren Group Ltd For: Dec 31
-
Form 10-K Synchrony Card Issuance For: Dec 31 Filed by: Synchrony Card Funding, LLC
-
Form 497 BNY Mellon Strategic
-
Form NT 10-K OPGEN INC For: Dec 31
-
Form MA/A CHITKARA RAVI
-
Form 8-K GALECTIN THERAPEUTICS For: Mar 29
-
Form 4 ACCO BRANDS Corp For: Mar 27 Filed by: Jotwani Pradeep
-
Form MA-A CIM INVESTMENT MANAGEMEN For: Dec 31
-
Form 10-K GALECTIN THERAPEUTICS For: Dec 31
-
Form 497 MAINSTAY FUNDS
-
Form 497 MAINSTAY FUNDS TRUST
-
Form 497K MAINSTAY FUNDS TRUST
-
Form DEFA14A NORFOLK SOUTHERN CORP
-
Form D TO21 Fund I, a series